Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)

Travere Therapeutics Inc. (NASDAQ:TVTX) is 1 of the 10 astir shorted biotech stocks to bargain according to hedge funds.

On February 19, Travere Therapeutics Inc. (NASDAQ:TVTX) released the 4th fourth net report. The institution registered U.S. nett merchandise income figures of $126.6 cardinal for the quarter, comparative to $73.5 cardinal during the 4th fourth of 2024. This translates into full-year U.S. nett merchandise income of $410.5 million, exhibiting astir 82% year-on-year growth. Such awesome figures were attributable to FILSPARI’s income growth.

The institution reported $2.7 cardinal successful nett income for the quarter, a important leap from a nett nonaccomplishment of $60.3 cardinal successful Q4 2024. Moreover, it held $322.8 cardinal successful currency & equivalents and marketable securities equilibrium arsenic of December 31, 2025. This equilibrium is expected to elevate further during the archetypal fractional of 2026, arsenic the institution anticipates a $25 cardinal sales-based milestone outgo from Mirum Pharmaceuticals.

On February 6, a mates of weeks anterior to the net announcement, Piper Sandler accrued the terms people connected Travere Therapeutics Inc. (NASDAQ:TVTX) from $35 to $38. The steadfast maintained its Neutral standing connected the stock, with an adjusted upside imaginable of astir 40% astatine the existent level. The accommodation came arsenic the steadfast reviewed and updated its estimates for respective commercialized companies pursuing respective fourth-quarter pre-releases and up of the quarterly announcements.

Travere Therapeutics Inc. (NASDAQ:TVTX) is simply a biopharmaceutical institution dedicated to identifying, developing, and delivering life-changing therapies for radical surviving with uncommon kidney and metabolic diseases. By focusing connected conditions with precocious unmet needs, specified arsenic IgA nephropathy and cystinuria, they strive to acceptable caller standards of attraction for patients.

While we admit the imaginable of TVTX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest successful According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.